首页> 外文期刊>BMC Ophthalmology >Fibrin membrane pupillary-block glaucoma after uneventful cataract surgery treated with intracameral tissue plasminogen activator: a case report
【24h】

Fibrin membrane pupillary-block glaucoma after uneventful cataract surgery treated with intracameral tissue plasminogen activator: a case report

机译:白内障组织纤溶酶原激活剂治疗白内障手术后纤维蛋白膜瞳孔阻滞性青光眼:一例

获取原文
           

摘要

Background Fibrin pupillary-block glaucoma is a rare complication after cataract surgery. The treatment for this condition is still controversial, since Nd:YAG laser fibrin membranotomy tends to reocclude and laser peripheral iridotomy entails the risk of damaging the corneal endothelium in the presence of corneal edema associated with elevated intraocular pressure. Case presentation A 62-year-old man with diabetes mellitus developed acute elevation of intraocular pressure with a shallow anterior chamber five days after uneventful cataract surgery. Initially, slit lamp examination provided only limited information due to severe corneal edema. After resolution of corneal edema with systemic glaucoma therapy, a complete fibrin membrane was observed across the pupil by slit lamp examination. Anterior segment optic coherence tomography clearly revealed a thin fibrin membrane covering the entire pupillary space, a shallow anterior chamber, and a deep posterior chamber. The intraocular lens was not observed by anterior segment optic coherence tomography. In contrast, ultrasound biomicroscopy, which has superior penetration depth, was able to visualize the intraocular lens deep in the posterior chamber. Injection of tissue plasminogen activator into the anterior chamber resulted in complete fibrinolysis and released the pupillary block. Conclusion This case suggests that ocular anterior segment imaging modalities, especially ultrasound biomicroscopy, serve as powerful diagnostic tools to identify mechanisms of acute angle closure glaucoma, which is often accompanied by poor intraocular visibility. This is the first reported case of fibrin pupillary-block glaucoma after cataract surgery successfully treated with intracameral tissue plasminogen activator.
机译:背景纤维蛋白性瞳孔阻滞性青光眼是白内障手术后罕见的并发症。由于Nd:YAG激光纤维蛋白膜切开术趋于闭塞,并且激光周边虹膜切开术存在在与升高的眼内压相关的角膜水肿的情况下损坏角膜内皮的风险,因此对于这种情况的治疗仍存在争议。病例介绍一名62岁的糖尿病男子在进行了正常的白内障手术5天后,眼内压急剧升高,前房变浅。最初,裂隙灯检查由于严重的角膜水肿仅提供了有限的信息。全身性青光眼治疗解决了角膜水肿后,通过裂隙灯检查在整个瞳孔上观察到完整的纤维蛋白膜。前段光学相干断层扫描清楚地显示出覆盖整个瞳孔空间的薄纤维蛋白膜,浅前房和深后房。前节段光学相干断层扫描未观察到人工晶状体。相比之下,具有更高穿透深度的超声生物显微镜能够可视化后房深处的人工晶状体。组织纤溶酶原激活物注入前房导致完全的纤维蛋白溶解并释放瞳孔阻滞。结论该病例表明眼前节段成像方式,尤其是超声生物显微镜,是确定急性闭角型青光眼机制的强有力的诊断工具,而急性闭角型青光眼通常伴有眼内可见度差。这是在白内障手术后成功应用前房组织纤溶酶原激活剂治疗的纤维蛋白瞳孔阻滞性青光眼的首例病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号